IDDI in the Media.
Read the articles related to our know-how and expertise in clinical research and how we optimize the design and conduct of clinical trials.
IDDI in the Media BIOWIN Newsletter Deux projets de R&D dans les starting-blocks (July 2017): “TREATBEST, est un consortium composé de Diagenode, IDDI, l’Université de Bruxelles, l’Institut Jules Bordet et l’Université de Liège. Ces acteurs unissent leur savoir à la science « […]
IDDI, an international functional Contract Research Organisation (CRO) headquartered in Belgium, replaced its mix of a paper-based trial master file (TMF) and e-rooms with Veeva Systems’ cloud-based Vault eTMF solution, part of Veeva’s Development Suite. As a CRO that collects, […]
A new Software for Risk-based Monitoring As biopharmaceutical sponsors search for the optimal approach to targeted monitoring and reduced Source Data Verification (SDV), CluePoints introduces an Intelligent Statistical approach like no other! A new software and service provider of Intelligent […]
Central Statistical Monitoring of Data Quality in Clinical Trials IDDI announces publication on Central Statistical Monitoring: ‘A statistical approach to central monitoring of data quality in clinical trials published in Clinical Trials’ on June 8th. Online version is available at: http://journals.sagepub.com/doi/abs/10.1177/1740774512447898 ABSTRACT […]
Integrated EDC IWRS system: The IWR/IVR system ID-netTM developed by IDDI now provides an interface to MARVIN, XClinical’s EDC system. About ID-netTM ID-netTM is an Interactive Web Response System (IWRS) for centralized randomization and treatment allocation developed by IDDI in […]
IDDI, announces that it has signed a collaborative agreement with I-BioStat, the Interuniversity Institute for Biostatistics and statistical Bioinformatics, which links research and consultancy groups at the Universities of Hasselt and Leuven in Belgium. The agreement will enable IDDI and […]
Successful Partnership with Tigenix for Approval of Chondrocelect for Cartilage Repair IDDI’s contributed statistical methodology towards approval of ChondroCelect® TiGenix’s lead product for the treatment of cartilage repair in the knee. Louvain-la-Neuve, August 27, 2009 – IDDI (International Drug Development […]